Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells

被引:41
作者
Bindels, EMJ [1 ]
Lallemand, F [1 ]
Balkenende, A [1 ]
Verwoerd, D [1 ]
Michalides, R [1 ]
机构
[1] Netherlands Canc Inst, Div Tumor Biol, NL-1066 CX Amsterdam, Netherlands
关键词
antiestrogens; Gl/S cyclins; breast cancer; cell cycle; estrogen receptor;
D O I
10.1038/sj.onc.1206012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Estrogen receptor-mediated transcription is enhanced by overexpression of G1/S cyclins D1, E or A in the presence as well in the absence of estradiol. Excess of G1/S cyclins also prevents the inhibition of transactivation of estrogen receptor (ER) by the pure antiestrogen ICI 182780. Cyclin D1 mediates this transactivation independent of complex formation to its CDK4/6 partner. This raises the possibility that overexpression of G1/S cyclins renders growth of ER-positive breast cancer hormone-independent and resistant to treatment with antiestrogens. Transient transfection of ER-positive breast cancer cell lines T47D and MCF7 with G1/S cyclins could overcome the growth arrest induced by ICI 182780 treatment. The ability of various cyclin D1 mutants to overcome the ICI 182780 mediated growth arrest corresponded with their ability to stimulate cyclin A- and E2F- promoter based reporter activities in the presence of ICI 182780. Transfection of a mutant cyclin D1 (cyclin D1-KE) that was unable to bind CDK4 and was reported to transactivate ER in the presence of ICI 182780, could not stimulate proliferation in ICI 182780 treated cells. On the other hand, cyclin D1-LALA, which is unable to stimulate ERE transactivation, could overcome the ICI 182780 cell cycle arrest. Furthermore, transient transfection of T47D cells using cyclin D1 together with a catalytic inactive mutant of CDK4 (CDK4-DN) indicated that the observed effect is due to binding to CDK inhibitors. However, a moderate, sixfold overexpression of cyclin D1 in stably transfected MCF7 cells did not overcome the ICI 182780 mediated growth arrest. These results indicate that CDK-independent transactivation of the estrogen receptor by cyclin D1 is by itself, not sufficient to result in estradiol-independent growth of breast cancer cells, whereas a vast overexpression of G1/S cyclins is able to do so, most likely by capturing of CDK inhibitors.
引用
收藏
页码:8158 / 8165
页数:8
相关论文
共 46 条
[1]   Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation [J].
Alt, JR ;
Cleveland, JL ;
Hannink, M ;
Diehl, JA .
GENES & DEVELOPMENT, 2000, 14 (24) :3102-3114
[2]  
Anderson JJ, 1996, J PATHOL, V180, P65, DOI 10.1002/(SICI)1096-9896(199609)180:1<65::AID-PATH607>3.0.CO
[3]  
2-C
[4]   Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E [J].
Bortner, DM ;
Rosenberg, MP .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (01) :453-459
[5]   Role of the Cdc25A phosphatase in human breast cancer [J].
Cangi, MG ;
Cukor, B ;
Soung, P ;
Signoretti, S ;
Moreira, G ;
Ranashinge, M ;
Cady, B ;
Pagano, M ;
Loda, M .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (06) :753-761
[6]   Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells [J].
Cariou, S ;
Donovan, JCH ;
Flanagan, WM ;
Milic, A ;
Bhattacharya, N ;
Slingerland, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (16) :9042-9046
[7]   A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence [J].
Carroll, JS ;
Prall, OWJ ;
Musgrove, EA ;
Sutherland, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (49) :38221-38229
[8]   Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquintin-proteasome pathway [J].
Diehl, JA ;
Zindy, F ;
Sherr, CJ .
GENES & DEVELOPMENT, 1997, 11 (08) :957-972
[9]   Steroidal and nonsteroidal oestrogen antagonists in breast cancer: basic and clinical appraisal [J].
Favoni, RE ;
de Cupis, A .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (10) :406-415
[10]   Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells [J].
Foster, JS ;
Wimalasena, J .
MOLECULAR ENDOCRINOLOGY, 1996, 10 (05) :488-498